Adding Dexmedetomidine or Tramadol to Paracetamol- An Effort to Attenuate Catheter Related Bladder Discomfort

Recruiting now · Phase 3

Conditions studied: Percutaneous Nephrolithotripsy (PCNL)

In brief

The insertion of a urinary catheter in a patient undergoing a surgical procedure, especially urinary interventions, may lead to catheter-related bladder discomfort (CRBD) with varying degrees of severity during the postoperative period. Paracetamol is a drug with proven efficacy for the management of mild and moderate postoperative pain. Tramadol is a centrally acting, synthetic opioid analgesic with weak opioid agonist properties. It inhibits the detrusor activity by inhibition of type-1 muscarinic (M1) and type-3 muscarinic (M3) receptors. Dexmedetomidine, a highly selective α2-adrenergic receptor agonist, with analgesic, sedative, anxiolysis, sympatholytic, and sedative properties, is a very useful associated agent for general anesthesia.

Key facts

Study ID

NCT06274333

Run by

Al-Azhar University

People needed

60

Starts

2024-02-28

Expected to finish

2026-09-30

Last updated by the study team

2026-01-06

Who can join

Age: 20 and older, up to 50. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Age from 20 - 50 years
• ASA (The American Society of Anesthesiologists) I or II,
• undergo percutaneous nephrolithotomy (PCNL)

You may not qualify if…

• Patients with history of psychotic illnesses
• Opioid users
• Bladder obstruction,
• Benign prostatic hyperplasia
• Overactive bladder (OAB) defined as frequency _3 times at night or _8 times within 24 hours.

Where it is running

• Neveen Kohaf — Cairo, Cairo Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.